MIRA Pharmaceuticals, Inc. Common Stock
Symbol: MIRA (NASDAQ)
1.60
▲ (5.33%) 0.081
Company Description:
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
Key Stats
- Today's Open: $1.53
- Today's High: $1.7
- Today's Low: $1.53
- Today's Volume: 1.75K
- Yesterday Close: $1.52
- Yesterday High: $1.58
- Yesterday Low: $1.41
- Yesterday Volume: 414.30K
- Last Min Volume: 0
- Last Min High: $1.683
- Last Min Low: $1.601
- Last Min VWAP: $0
Company Profile
- Name: MIRA Pharmaceuticals, Inc. Common Stock
- Website: https://www.mirapharmaceuticals.com
- Listed Date: 2023-08-03
- Location: MIAMI, FL
- Market Status: Active
- CIK Number: 0001904286
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $28.99M
- Round Lot: 100
- Outstanding Shares: 19.07M
- Asset Type: CS
RECENT FILINGS FOR MIRA
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-03 | 4 | View |
| 2025-08-19 | 8-K | View |
| 2025-08-14 | 10-Q | View |
| 2025-08-12 | 8-K | View |
| 2025-08-08 | DEFM14A | View |
| 2025-08-08 | DEFA14A | View |
| 2025-07-29 | PRER14A | View |
| 2025-07-29 | 8-K | View |
| 2025-07-28 | 8-K | View |
| 2025-07-10 | 8-K | View |
| 2025-07-08 | 8-K | View |
| 2025-07-02 | 8-K | View |
| 2025-06-30 | 8-K | View |
| 2025-06-24 | 8-K | View |
| 2025-06-17 | 8-K | View |
| 2025-06-17 | PREM14A | View |
| 2025-06-10 | 3 | View |
| 2025-05-28 | 8-K | View |
| 2025-05-21 | 8-K | View |
| 2025-05-14 | 10-Q | View |
Latest News on MIRA